Fraud and Abuse | Physicians Lawyers

Category Archives Fraud and Abuse

Navigating False Claims Act Liability and Damages—The Importance of Compliance Programs for Healthcare Providers

Posted on July 13, 2026 8:12 am by admin

Understanding FCA Risks and How Compliance Can Protect Your Practice

Executive summary: FCA exposure can escalate quickly when billing errors repeat across many claims. This alert explains the conduct that can trigger FCA liability, illustrates how statutory penalties and treble damages can compound financial exposure, and outlines why healthcare providers should maintain active compliance programs to identify, correct, and document billing issues before they become systemic.

The federal False Claims Act (FCA) is one of the government’s primary tools for addressing allegedly false or fraudulent claims submitted to federal healthcare programs. Healthcare providers face heightened FCA risk because Medicare and Medicaid billing involves high claim volume, complex coding rules, and evolving reimbursement requirements. For medical practices, understanding how FCA liability arises—and how quickly penalties and damages can escalate—is essential to maintaining effective billing controls and protecting the organization’s financial stability.

FCA Liability: What Triggers It?

Liability under the FCA arises when an individual or entity knowingly submits, or causes to be submitted, a false or fraudulent claim for payment to the federal government. For FCA purposes, “knowingly” includes actual knowledge, deliberate ignorance, or reckless disregard of the truth or falsity of the claim; proof of specific intent to defraud is not required. Common triggers include incorrect coding, upcoding, unbundling, and billing for services not rendered. Repeated billing errors can create significant exposure, particularly if they suggest weaknesses in controls or a failure to investigate and correct known problems.

Fictitious Damages Calculation: Systematic Billing Error Scenario

To illustrate the magnitude of FCA exposure, consider a hypothetical medical practice that incorrectly billed a particular code five times per day over five years. Assuming 260 working days per year, this results in 5 claims x 260 days x 5 years = 6,500 potentially false claims submitted.

Under the FCA, each false claim may carry a statutory civil penalty in addition to treble damages. Using 2026 penalty figures for this illustration, the total minimum penalty would be 6,500 claims x $13,946 = $90,649,000. The total maximum penalty would be 6,500 claims x $27,894 = $181,311,000. These figures are separate from any damages based on the alleged overpayment, which may be trebled under the FCA.

Assuming each of these 6,500 false claims was for $100, the total overpayment would be 6,500 x $100 = $650,000. If trebled, that amount would rise to $1,950,000. Adding the 2026 statutory penalties described above produces a total illustrative liability range of $92,599,000 to $183,261,000, before considering any other costs, collateral consequences, or settlement factors.

Therefore, the total illustrative liability would consist of trebled damages plus statutory penalties. Using the assumptions above, minimum liability would be $1,950,000 in trebled damages plus $90,649,000 in minimum penalties, yielding $92,599,000. Maximum liability would be $1,950,000 plus $181,311,000 in maximum penalties, yielding $183,261,000. This example demonstrates how even a modest per-claim overpayment can become an existential financial threat under the FCA, further underscoring the need for rigorous compliance protocols.

Item	Calculation	Minimum Amount	Maximum Amount
Total False Claims	5 claims/day x 260 days/year x 5 years	6,500 claims	6,500 claims
Statutory Civil Penalty (2026 figures)	6,500 claims x [penalty per claim]	$90,649,000 (6,500 x $13,946)	$181,311,000 (6,500 x $27,894)
Total Overpayment	6,500 claims x $100	$650,000	$650,000
Trebled Damages	$650,000 x 3	$1,950,000	$1,950,000
Total Liability	Statutory Civil Penalty + Trebled Damages	$90,649,000 + $1,950,000 = $92,599,000	$181,311,000 + $1,950,000 = $183,261,000

Astronomical Damages: Financial Risks and Impact

The potential damages under the FCA can be truly astronomical, threatening the financial viability of even well-established practices. The sheer scale of penalties for systematic errors underscores the importance of vigilance and proactive risk management. Providers found liable may face not only monetary penalties but also reputational harm and exclusion from federal programs.

The Importance of Compliance Programs

Ongoing compliance programs are a critical tool for reducing FCA risk. By establishing robust policies, conducting regular training, and performing periodic audits, practices can detect and correct billing errors before they become systemic. Compliance programs encourage a culture of accountability and transparency, helping staff understand legal requirements and billing expectations. A well-documented compliance program may also support mitigation arguments if issues arise, although it does not eliminate liability for false claims.

Compliance programs also provide guidance on evolving regulations, helping providers adapt to changes in billing standards and maintain ethical practices. Investing in compliance is not just a legal necessity; it is a strategic safeguard that protects the practice’s finances, reputation, and continued ability to serve patients.

Conclusion: Key Takeaways and Recommendations

FCA liability poses significant risks for healthcare providers, with the potential for substantial damages stemming from even repeated billing errors involving modest individual amounts. The best risk-management approach is a strong, ongoing compliance program that promotes accuracy, accountability, and ethical conduct. Healthcare providers should regularly review billing practices, audit high-risk codes, train staff on coding and documentation requirements, document corrective actions, and consult legal counsel when potential overpayments or systemic issues are identified. Proactive measures today can help prevent costly disputes tomorrow.

This entry was posted in Compliance Programs, False Claims Act, Fraud and Abuse, OFfice of Inspector General. Bookmark the permalink.

CPOM in Telehealth: What the Corporate Practice of Medicine Means for Virtual Care Companies

Posted on June 27, 2026 1:21 am by admin
CPOM in telehealth is a significant legal and regulatory issue for virtual care companies, medical practices, investors, and management services organizations. Although telehealth may facilitate the delivery of health care across geographic boundaries, corporate practice of medicine laws remain largely state-specific and may affect ownership of the professional practice, control over clinical decision-making, the flow of professional revenue, and compensation for non-clinical support services. For organizations developing, acquiring, or expanding a virtual care model, early analysis of telehealth corporate practice of medicine requirements can mitigate restructuring risk, enforcement exposure, and transaction delays.

Principal Issue of CPOM in Telehealth

The principal compliance issue is straightforward in concept but complex in application: business entities may provide support to a medical practice, but they generally may not engage in the practice of medicine. In the telehealth context, that distinction may become less clear. A technology platform may schedule visits, collect intake information, route patients to clinicians, support billing functions, coordinate marketing administration, and provide virtual care infrastructure. Although those services may be non-clinical, the organization must avoid exercising control over diagnosis, treatment, prescribing, clinical protocols, or professional judgment.

This article addresses how CPOM in telehealth affects common business models, why management services organization and professional entity structures are frequently used, how fee-splitting restrictions may create additional risk, and what organizations should evaluate before launching, acquiring, or scaling a virtual care platform.

Listen to our Legal Pulse Podcast on CPOM in Telehealth

Listen Now!

Why CPOM in Telehealth Matters
- Telehealth corporate practice of medicine rules generally require licensed clinicians to retain control over diagnosis, treatment, prescribing, clinical protocols, and patient-care decisions.
- Non-clinical companies, platforms, and MSOs should avoid owning, operating, or controlling the professional medical practice in ways that violate state CPOM laws.
- Management fees should be commercially reasonable, supported by fair market value, and not structured as disguised payments for referrals or professional fee-splitting.
- Because CPOM and fee-splitting laws vary by state, multi-state telehealth companies need jurisdiction-specific legal review before launch or expansion.
What Is the Corporate Practice of Medicine in Telehealth?

The corporate practice of medicine doctrine generally prohibits non-licensed business entities from practicing medicine, employing physicians to provide professional clinical services, or interfering with medical judgment. In a telehealth corporate practice of medicine analysis, the central inquiry is whether licensed providers—not investors, technology vendors, marketing companies, or MSOs—retain responsibility for clinical decision-making. These decisions include diagnosis, treatment plans, prescribing, supervision of clinical personnel, medical record policies, patient communications concerning care, and the provider-patient relationship.

The doctrine is grounded in the principle that medical judgment should be exercised by licensed professionals who owe ethical and professional obligations to patients. If a non-clinical entity pressures providers to follow business-driven treatment protocols, limits clinical discretion, controls the hiring or termination of clinicians, or influences prescribing decisions, regulators may view the arrangement as an impermissible exercise of corporate control over medicine. Depending on the jurisdiction, violations may result in licensure action, unenforceable contracts, repayment exposure, civil liability, or criminal penalties.

Telehealth makes these questions more complex because the patient, provider, platform, professional entity, and management company may all be located in different states. A company headquartered in one state may deliver services to patients in many others. For CPOM purposes, the relevant analysis often turns on the laws of the states where patients are located and where professional services are delivered, not merely where the business is organized.

How CPOM Affects Telehealth Business Models

CPOM in telehealth often shapes the relationship between a physician-owned professional entity and a management services organization. In many models, the professional entity provides clinical services and receives professional revenue, while the MSO provides non-clinical services such as billing support, scheduling, technology infrastructure, accounting, marketing administration, human resources support, compliance administration, payor enrollment support, and back-office operations. This structure can reduce risk when the MSO does not control clinical policies, provider supervision, prescribing decisions, or other professional judgment.

Management Service Organization and CPOM in Telehealth

The professional entity/MSO model is not, by itself, dispositive. Contractual documentation must be consistent with operational reality. If an MSO states that it provides only administrative services but, in practice, determines which clinical services are offered, selects clinical protocols, controls provider scheduling in a manner that affects care, or terminates clinicians for exercising independent judgment, the structure may still present CPOM concerns. Regulators and payors may evaluate how the arrangement operates in practice, not solely how it is described in the agreements.

Document Flow of Funds to Mitigate CPOM in Telehealth

Companies should also document the flow of funds. In a lower-risk structure, professional revenue is generally received by the professional practice, and the MSO is paid for defined non-clinical services under a written management agreement. Compensation should be commercially reasonable and supported by fair market value analysis. Recent federal guidance regarding telehealth MSO arrangements has also emphasized the importance of fees that are set in advance, supported by valuation, and not dependent on referrals, patient volume, or payor reimbursement.

Common Red Flags in Telehealth CPOM Structures
- The MSO or platform controls clinical protocols, prescribing standards, or treatment pathways without meaningful provider discretion.
- A non-clinical company can hire, fire, discipline, or supervise clinicians based on clinical judgment or patient-care decisions.
- Management fees are calculated as a percentage of professional revenue without state-specific fee-splitting review.
- Marketing or lead-generation payments vary based on patient conversions, referrals, or ordered services.
- Contracts describe compliant separation, but day-to-day operations give the business entity practical control over medical decisions.
CPOM in Telehealth Compliance Checklist
- Confirm that licensed clinicians retain control over diagnosis, treatment, prescribing, clinical protocols, and patient-care decisions.
- Separate clinical services from non-clinical business functions in the operating model and contracts.
- Define the MSO’s role as limited to administrative and operational support services.
- Support management fees with fair market value analysis and commercial reasonableness documentation.
- Avoid compensation formulas tied to referrals, patient volume, professional fees, or increased utilization.
- Conduct state-specific CPOM and fee-splitting review before launching, acquiring, or expanding telehealth operations.
- Evaluate federal Stark Law and anti-kickback statute implications where federal health care program reimbursement or referral relationships are involved.
Frequently Asked Questions About CPOM in Telehealth

Does CPOM apply to telehealth companies?

Yes. Telehealth companies are generally subject to the corporate practice of medicine rules in the states where patients receive care. A virtual delivery model does not eliminate the obligation to comply with state professional practice requirements.

Can an MSO manage a telehealth practice?

An MSO may provide non-clinical management services, but it should not control medical judgment, clinical protocols, prescribing, provider supervision, or other professional decisions. The services and compensation should be clearly documented.

Why are percentage-based fees risky in telehealth?

Percentage-based fees can raise fee-splitting and referral concerns if they appear tied to professional revenue, patient volume, or business generated for the practice. Some states scrutinize or restrict these arrangements more heavily than others.

What is the difference between CPOM and fee splitting?

CPOM focuses on who may own, operate, or control a medical practice and who may exercise clinical judgment. Fee-splitting rules focus on whether professional fees are being shared with non-licensed persons or entities in an impermissible way. In telehealth, both issues often arise together because the same MSO, platform, or investor relationship may affect both control and compensation.

When should a telehealth company review CPOM compliance?

CPOM in telehealth review should occur before launch, before entering a new state, before changing compensation terms, before signing major MSO or platform agreements, and before a financing or acquisition transaction. Waiting until diligence can create avoidable delays and may require restructuring under time pressure.

Can one telehealth corporate practice of medicine structure work nationwide?

In most cases, a single template is insufficient. An organization may use a consistent overall framework, but the details often must be adapted to address state ownership rules, professional entity requirements, supervision rules, fee-splitting restrictions, and payor contracting expectations.

Address CPOM Issues in Telehealth

CPOM in telehealth should be addressed at the outset of the transaction or business planning process—not after operations have commenced. A compliant telehealth corporate practice of medicine structure should preserve independent clinical judgment, separate professional and non-clinical functions, document fair market value compensation, and account for state-by-state variation. The structure should also be operationally consistent: contracts, governance documents, workflows, training materials, compensation terms, and day-to-day practices should support the same compliance position.

Conclusions About CPOM in Telehealth

As virtual care continues to expand, regulators, payors, and transaction counterparties are likely to continue scrutinizing who controls the medical practice and how funds move through the model. Organizations that treat CPOM and fee-splitting compliance as a core component of business design—not merely as a legal memorandum—will be better positioned to scale, attract investment, and maintain durable provider relationships.

The key takeaway is that CPOM in telehealth corporate practice of medicine compliance is not limited to selecting the appropriate entity form. It requires maintaining a defensible separation between clinical authority and business support, documenting fair value for services, avoiding referral-driven compensation, and updating the structure as the organization grows. Early guidance from experienced health care counsel and valuation professionals can help reduce enforcement risk and support a durable virtual care business model.
This entry was posted in AntiKickback Statute and Regulations, Concierge Medical Practices, Fraud and Abuse, Health Law Practice, Hospital Issues, Telemedicine and tagged corporate practice of medicine, cpom, Telehealth, telehealth compliance, Telemedicine. Bookmark the permalink.
ASC Safe Harbors: The Silent Partner Physician and Compliance Pitfalls

Posted on June 2, 2026 5:50 am by admin
Lessons from a Real-World Case Study in Ambulatory Surgery Center Ownership

When it comes to Ambulatory Surgery Centers (ASCs), compliance with federal regulations is essential, especially regarding ASC Safe Harbors. Many surgery centers strive to boost their business by engaging physicians as owners. However, even seemingly harmless arrangements can cross legal boundaries, putting the entire facility at risk.

A Cautionary Tale: The Silent Partner Physician

Imagine a scenario in which a physician’s name appears on the ASC ownership roster, yet the facts tell a different story. A capital contribution that never materializes. Distributions that rise and fall, seemingly in lockstep with referral volume. And the clincher: an internal email stating, “We need him on the cap table to keep his cases here.” This is the story of the Silent Partner Physician — a case that highlights how overlooking ASC Safe Harbor rules can lead to textbook violations.

Segment 1 — The Setup

The ASC at the center of this story was a small, high‑volume orthopedic facility. Like many ASCs, its financial health depended heavily on a few surgeons who generated most of its cases. One of those surgeons — let’s call him Dr. X — was invited to join as an investor. He signed all the necessary paperwork and was officially added to the ownership schedule.

But here’s the compliance pitfall: Dr. X never actually contributed capital. There was no check, no promissory note, nothing. Despite this, Dr. X began receiving quarterly distributions within months. This immediately raises red flags for ASC Safe Harbor compliance, which requires bona fide investment and risk.

Segment 2 — The Pattern Emerges

At first, the payments to Dr. X were small and almost symbolic. However, a troubling pattern soon surfaced:
- When Dr. X’s case volume increased, his distributions increased.
This direct relationship between referrals and financial rewards is exactly what ASC Safe Harbors are designed to prevent. The lack of a real investment, combined with compensation linked to case volume, exposes the ASC to significant legal and regulatory repercussions.

Key Takeaways for ASC Owners and Administrators
- Follow ASC Safe Harbor requirements: Ensure every physician-owner makes a legitimate capital contribution and bears real financial risk.
- Avoid tying distributions to referral patterns: Distributions should be based on ownership percentages, not case volume or referral numbers.
- Document compliance: Maintain thorough records of every investment and distribution. Transparency is crucial for defending your ASC in the event of an audit.
- Educate your partners: Make sure all physician investors understand ASC Safe Harbor and anti-kickback rules to avoid accidental violations.
Conclusion

The story of the Silent Partner Physician serves as a warning: even well-intentioned ownership arrangements can cross into dangerous territory if ASC Safe Harbor rules aren’t strictly followed. To safeguard your ASC, prioritize compliance, transparency, and education—because when it comes to healthcare law, ignorance is never a defense.

Looking to learn more about ASC Safe Harbors or need a legal compliance check-up? Consult our qualified physicians’ healthcare attorney or compliance expert to keep your surgery center on the right side of the law.
This entry was posted in Ambulatory Surgery Centers, AntiKickback Statute and Regulations, Fraud and Abuse, Health Law Practice, Legal Pulse Podcast, Medical Practices, Medicare, OFfice of Inspector General, Safe Harbor Regulations and tagged Ambulatory Surgery Centers, Anti-kickback Statute.Safe Harbor Regulations, ASC Safe Harbor, False Claims Act, lawyers for ASCs, physician ownership. Bookmark the permalink.
Podcast Episode 2: An Overview of the Stark Law & New Developments

Posted on June 1, 2026 11:53 am by admin

The Stark Law, formally known as the Physician Self-Referral Law, is a federal statute that prohibits physicians from referring patients for certain designated health services to entities with which they have a financial relationship, unless specific exceptions apply. The law is designed to prevent conflicts of interest and ensure that medical decisions are made in the best interest of patients, not influenced by financial gain. Violations of the Stark Law can result in significant penalties, including fines and exclusion from federal health programs.

Recently, there has been notable regulatory silence regarding updates or enforcement guidance for the Stark Law. This lack of clarity may leave physicians uncertain about compliance requirements, especially as healthcare practices evolve and new care models emerge.

What might this regulatory silence mean for physicians, and should they be concerned about potential changes or enforcement actions in the near future?

[Play Episode 2]

This entry was posted in Fraud and Abuse, Health Law Practice, Legal Pulse Podcast, Medicare, Physician Compensation Issues, Stark Law and tagged False Claims Act, Health law podcasts, Stark Law, Stark Regulations. Bookmark the permalink.
Podcast – The Ambulatory Surgery Center Safe Harbors – General Overview

Posted on June 1, 2026 10:44 am by admin

Ambulatory Surgery Center (ASC) Safe Harbors are legal provisions designed to protect certain arrangements involving ASCs from liability under the federal Anti-Kickback Statute. These Safe Harbors outline specific criteria that must be met for ASC transactions—such as investment interests and referral relationships—to be considered exempt from prosecution. By adhering to these guidelines, ASCs can ensure compliance and minimize legal risks associated with improper financial incentives.

The Safe Harbors cover a range of scenarios, including physician ownership, joint ventures, and payment structures. They require transparent operations, fair market value compensation, and documentation of legitimate business purposes. Understanding and applying these Safe Harbors is essential for ASCs to maintain ethical practices and avoid regulatory penalties.

[Play Episode 3]

This entry was posted in Ambulatory Surgery Centers, AntiKickback Statute and Regulations, Fraud and Abuse, Health Law Practice, Medical Practices, Safe Harbor Regulations and tagged Ambulatory Surgery Centers, Anti-kickback Statute.Safe Harbor Regulations, ASC Safe Harbor. Bookmark the permalink.
Understanding the Stark Law Period of Disallowance

Posted on June 1, 2026 5:50 am by admin
Stark Law Period of Disallowance Guide for Healthcare Professionals

Stark Law Period of Disallowance Compliance. The Stark Law, formally known as the Physician Self-Referral Law, is a federal statute designed to prevent physicians from referring patients to entities with which they have a financial relationship, unless an exception applies. The primary purpose of the Stark Law is to safeguard the integrity of medical decision-making and prevent conflicts of interest that could compromise patient care. Compliance is critical, as violations can result in severe penalties, including repayment obligations, civil monetary penalties, and exclusion from federal healthcare programs.

What is Stark Law Period of Disallowance

The Stark Law period of disallowance is a significant concept in the enforcement of federal law governing physician referrals for designated health services, as defined by statute and regulation. Pursuant to 42 U.S.C. § 1395nn(h)(6) and 42 C.F.R. § 411.351, designated health services include the following:
1. Clinical laboratory services.
2. Physical therapy, occupational therapy, and outpatient speech-language pathology services.
3. Radiology and certain other imaging services.
4. Radiation therapy services and supplies.
5. Durable medical equipment and supplies.
6. Parenteral and enteral nutrients, equipment, and supplies.
7. Prosthetics, orthotics, and prosthetic devices and supplies.
8. Home health services.
9. Outpatient prescription drugs.
10. Inpatient and outpatient hospital services.
The period of disallowance denotes the period during which referrals and any related claims are prohibited upon the existence of a financial relationship that fails to comply with the Stark Law and its implementing regulations. The period of disallowance generally commences when the noncompliant financial arrangement is established and continues until the arrangement is either terminated or brought into compliance. During such period, any Medicare or Medicaid claims arising from prohibited referrals are not payable, and the provider must undertake corrective action to remedy the underlying noncompliance.

Legal Background on the What is Stark Law Period of Disallowance

The statutory and regulatory framework for the Period of Disallowance stems from Section 1877 of the Social Security Act and is further clarified by regulations issued by the Centers for Medicare & Medicaid Services (CMS). The law outlines prohibited financial relationships and sets forth exceptions that may apply. CMS regulations provide guidance on how to address violations, including the calculation and management of disallowance periods. The concept was introduced to ensure that improper financial relationships are corrected and that claims submitted during the violation are appropriately handled.

Stark Law Period of Disallowance Calculation Methods

Determining the Period of Disallowance requires careful analysis of the facts surrounding the violation. The period begins at the inception of the non-compliant financial arrangement, such as an improper lease or compensation agreement, and continues until the arrangement is terminated or corrected. Correction may involve repaying excess compensation, renegotiating terms to meet compliance standards, or ending the relationship altogether. The CMS has issued guidance clarifying that the period does not retroactively apply to arrangements corrected before any prohibited referrals occur, but it does encompass all claims submitted during the period of non-compliance.

Implications for Healthcare Providers

For healthcare providers, the Period of Disallowance has significant operational and financial repercussions. Providers must identify and disclose non-compliant arrangements promptly to minimize the period and associated liabilities. Claims submitted for services rendered during the disallowance period may be denied or subject to repayment, and providers may face penalties if violations are not addressed in a timely manner. Maintaining robust compliance programs and conducting periodic audits are essential strategies to prevent and manage disallowance periods effectively.

Practical Examples Stark Law Period of Disallowance

Consider a scenario where a physician enters into a lease agreement with a hospital for office space at below-market rates, violating the fair market value requirement under the Stark Law. The Period of Disallowance would begin when the arrangement was established and continue until the lease terms are adjusted to comply with fair market value standards. All referrals and related claims during this period would be disallowed. Another example involves a compensation arrangement that exceeds regulatory limits; once identified, the provider must repay excess amounts and bring the agreement into compliance to end the disallowance period.

Best Practices for Managing Disallowance Periods

• Conduct regular reviews of all financial relationships to ensure compliance with the Stark Law.
• Establish clear policies and procedures for identifying and correcting non-compliant arrangements.
• Maintain thorough documentation of corrective actions and communications with regulatory authorities.
• Train staff and legal counsel on Stark Law requirements and the significance of the Period of Disallowance.
• Seek guidance from CMS and legal experts when addressing complex arrangements or potential violations.

The Period of Disallowance under the Stark Law is a crucial mechanism for enforcing compliance and protecting the integrity of federal healthcare programs. Understanding its definition, calculation, and implications enables healthcare providers and legal professionals to navigate complex regulatory requirements and avoid costly penalties. By adopting best practices and maintaining vigilant oversight of financial relationships, organizations can minimize risk and ensure ongoing compliance with the Stark Law.
This entry was posted in Fraud and Abuse, Health Law Practice, Stark Law. Bookmark the permalink.
Recent Regulatory Developments Shaping Medical Practice Structures and Ancillary Services

Posted on May 17, 2026 8:28 am by admin

Regulatory Developments Impacting Medical Practice Structures and Ancillary Services

The health care sector is undergoing continual transformation in response to evolving regulations and policy directives. Recent modifications at both federal and state levels are exerting considerable influence on the organization of medical practices and their ancillary services. This newsletter presents an overview of key regulatory developments and examines their potential implications for medical practices, physician groups, and affiliated health care services.

As regulatory updates reshape the landscape, medical organizations must remain vigilant, actively assessing how new laws and policies impact practice structure, provider roles, and the delivery of ancillary services. From adjustments to federal regulations such as the Stark Law and Anti-Kickback Statute, to state-driven scope of practice reforms and expanded telehealth opportunities, each change presents both operational challenges and opportunities for innovation. By closely monitoring these developments and adapting internal protocols accordingly, practices can maintain compliance, optimize patient care, and ensure sustainability in a rapidly evolving environment.

1. Stark Law and Anti-Kickback Statute Updates

The Centers for Medicare & Medicaid Services (CMS) and the Office of Inspector General (OIG) have implemented crucial revisions to the Stark Law and Anti-Kickback Statute regulations. The updates aim to facilitate value-based arrangements while maintaining strong safeguards against fraud and abuse. These changes allow for greater flexibility in structuring physician compensation and the use of ancillary services, as long as arrangements are designed to improve quality and efficiency. However, practices must continue to exercise caution and ensure compliance with specific exceptions and safe harbors.

In light of these regulatory enhancements, medical practices must thoroughly evaluate how their current arrangements align with the updated standards. This includes reviewing contracts with physicians and ancillary service providers to confirm that any value-based incentives or shared savings models meet the newly defined criteria for permissible practices. Enhanced documentation and regular compliance audits are recommended to ensure that all compensation structures remain within the boundaries of the law and that practices are prepared for potential regulatory scrutiny.

Additionally, the changes reinforce the importance of transparency and accountability in financial relationships. Practices should implement training programs for staff and leadership to ensure a clear understanding of the revised regulations, focusing on the practical implications for day-to-day operations. By fostering a culture of compliance and staying informed about ongoing regulatory updates, organizations can mitigate risks and leverage new opportunities presented by the evolving value-based care landscape.

2. State-Level Scope of Practice Reforms

Several states have enacted laws expanding the scope of practice for nurse practitioners, physician assistants, and other non-physician providers. These reforms are intended to address workforce shortages and improve patient access to care. Medical practices should review their organizational structures and supervision protocols to align with the new regulations, which may also affect how ancillary services are delivered and billed.

In addition, as states refine these scope of practice laws, medical practices must stay alert to evolving supervisory requirements and collaborative agreements, as well as any changes to credentialing standards for non-physician providers. It is essential for organizations to update internal policies and procedures to reflect these legal adjustments, ensuring that all clinical staff operate within their authorized scope and that documentation supports compliance with both state and payer expectations. These proactive steps will position practices to adapt efficiently to the regulatory landscape while continuing to provide high-quality, accessible care to their patient populations.

As the scope of practice for non-physician providers broadens, medical practices may also encounter changes in liability, risk management, and insurance requirements. It is advisable for organizations to consult with risk professionals and legal advisors to assess how these new laws may impact malpractice coverage and the delegation of clinical responsibilities. Establishing clear protocols for communication and decision-making can help mitigate potential risks associated with expanded provider roles.

Furthermore, ongoing education and training for both clinical and administrative staff remain critical as scope of practice regulations evolve. Regularly scheduled workshops or updates can ensure that all team members are aware of the latest requirements, fostering a collaborative environment that prioritizes compliance and patient safety. By investing in continuous professional development and updating onboarding materials to reflect new legal standards, practices can support their staff in delivering care that meets both regulatory and quality benchmarks.

Ultimately, adapting to state-level scope of practice reforms presents both a challenge and an opportunity for medical practices. Those that proactively address regulatory updates by revising policies, training staff, and streamlining workflows will be best positioned to enhance patient access, maximize operational efficiency, and maintain legal compliance in a changing health care landscape.

3. Telehealth Expansion and Reimbursement Policies

The regulatory environment for telehealth continues to shift, with many temporary waivers granted during the COVID-19 public health emergency now being codified or extended. Both Medicare and some commercial payers are expanding coverage for telemedicine visits and related ancillary services such as remote patient monitoring. Practices integrating telehealth must ensure compliance with licensure, privacy, and billing requirements, as these remain areas of regulatory focus.

As telehealth becomes a more integral part of care delivery, practices must also monitor state and federal legislative updates that may further influence how telemedicine services are provided and reimbursed. This includes staying current with evolving technology standards, addressing cross-state licensure challenges, and adapting to payer-specific requirements for claim submission and documentation. By proactively updating protocols and engaging in ongoing staff training, organizations can ensure that telehealth services remain compliant, efficient, and accessible for patients, while also supporting broader organizational goals for quality and innovation.

In addition to regulatory compliance, medical practices should evaluate the operational impact of telehealth expansion on ancillary services. For example, remote patient monitoring, virtual consultations, and digital diagnostics can enhance patient engagement and improve clinical outcomes, but they also require robust technology infrastructure and secure data management processes. Establishing clear workflows for scheduling, documenting, and billing telehealth encounters will help practices avoid errors and ensure appropriate reimbursement.

Furthermore, practices should consider the implications of telehealth on patient privacy and data security, especially in light of evolving HIPAA guidelines and state-specific privacy laws. Implementing end-to-end encryption, multi-factor authentication, and regular cybersecurity training for staff can help safeguard patient information during virtual visits.

Finally, as patient expectations for convenience and accessibility continue to rise, practices embracing telehealth are well-positioned to attract and retain patients. By prioritizing user-friendly technology platforms, offering technical support, and soliciting patient feedback, organizations can enhance the overall telemedicine experience. Ongoing evaluation of telehealth services and outcomes will allow practices to refine their offerings and remain competitive as the regulatory and reimbursement landscape continues to evolve.

4. Corporate Practice of Medicine and Management Services Organizations

States continue to clarify and, in some cases, tighten restrictions around the corporate practice of medicine (CPOM). Recent enforcement actions underscore the importance of structuring management services organizations (MSOs) and related entities in ways that do not violate CPOM prohibitions. Medical practices should consult legal counsel to confirm that their business relationships with ancillary service providers adhere to these evolving standards.

To mitigate risks associated with CPOM, organizations should regularly review their contractual arrangements and operational structures. This includes ensuring that all clinical decision-making remains under the control of licensed physicians, while MSOs and other non-clinical partners limit their activities to administrative and business support functions. Clear documentation of these boundaries, as well as periodic audits of management arrangements, can help practices demonstrate compliance in the event of regulatory scrutiny.

Additionally, as enforcement priorities shift, practices in multiple states must pay close attention to varying state-specific definitions and interpretations of CPOM. Maintaining open lines of communication with legal and compliance experts can help organizations respond quickly to regulatory changes and avoid unintentional violations. By fostering a culture of transparency and compliance, medical practices can safeguard their operations and continue to deliver high-quality patient care within the boundaries of the law.

5. Ancillary Service Billing and Compliance

The OIG and Department of Justice have increased scrutiny of billing practices related to ancillary services, such as laboratory testing, imaging, and physical therapy. Recent settlements highlight the risks associated with improper billing, upcoding, or the provision of medically unnecessary services. Practices must review their compliance programs and ensure that all ancillary service arrangements are properly documented and justified.

To further support compliance, organizations should implement regular internal audits of their ancillary service billing and coding processes. These reviews help identify discrepancies and potential areas of risk before they escalate into legal or financial issues. Providing ongoing education and training for staff involved in billing, coding, and documentation is also crucial, as regulatory requirements and payer policies frequently change.

In addition, practices should develop clear protocols for verifying medical necessity and obtaining appropriate documentation for all ancillary services rendered. Leveraging technology, such as electronic health records and billing software with built-in compliance checks, can streamline these processes and reduce the likelihood of errors. Engaging compliance officers or external consultants to periodically review ancillary service arrangements can provide valuable insights and help maintain adherence to federal and state regulations.

Ultimately, a proactive approach to ancillary service billing and compliance not only minimizes regulatory risk but also supports the delivery of high-quality patient care. By fostering a culture of transparency and accountability, medical practices position themselves to respond effectively to evolving enforcement priorities and maintain trust with patients and payers.

Conclusion

Recent regulatory developments are reshaping the landscape for medical practices and their ancillary services. Staying informed and proactive in adapting to these changes is essential for maintaining compliance and optimizing practice operations. We recommend consulting with legal and compliance experts to ensure your practice is prepared for both current and future regulatory shifts.

Thank you for reading. For more information or to discuss how these changes may affect your practice, please contact our health care advisory team.

This entry was posted in Fraud and Abuse, Health Law Practice, Medical Practices, Safe Harbor Regulations, Telemedicine. Bookmark the permalink.
How is AI Changing False Claims Act Enforcement

Posted on May 17, 2026 7:31 am by admin
What Organisations Should Know as AI is Changing False Claims Act Fraud Risk, Compliance Operations and Enforcement

Artificial intelligence is AI is Changing False Claims Act enforcement and the way organizations identify compliance risk. The government was already on the path to implementing AI solutions for fraud detection before AI emerged as an available tool to detect potential fraud. For healthcare providers, government contractors, and other recipients of federal funds, that shift matters because the False Claims Act remains one of the government’s most powerful enforcement tools.

AI can help organizations strengthen internal controls, detect billing or contracting issues earlier, and respond more efficiently to potential problems. It can also make government investigations faster and more data-driven.

The federal False Claims Act is the government’s primary civil anti-fraud law for addressing false or misleading claims for payment submitted to federal programs or contracts. In simple terms, it allows the government—and in some cases private whistleblowers acting on the government’s behalf through qui tam lawsuits—to pursue companies or individuals that knowingly seek federal funds they are not entitled to receive.

Just as importantly, a company’s failure to maintain an effective compliance program can be powerful evidence of the knowledge required to support liability. Violations can lead to repayment, significant civil penalties, and treble damages, which helps explain why the statute remains such a powerful enforcement tool.

For example, if a contractor knowingly bills Medicare for medical services that were never provided, the government can use the False Claims Act to recover the money and impose additional penalties.
- The False Claims Act is a primary federal anti-fraud law.
- It applies to knowingly false or misleading claims for federal payment.
- Whistleblowers may bring qui tam actions on the government’s behalf.
- Weak compliance controls can increase enforcement risk.
- Exposure may include repayment, penalties, and treble damages.
What AI Means for Compliance Programs

For many organizations, the most immediate value of AI is in day-to-day compliance monitoring. AI-enabled tools can assist with real-time review of transactions, contracts, and claims, helping compliance teams identify unusual patterns before they become larger problems.

In practice, these tools may include transaction-monitoring platforms that flag anomalous payment activity, claims-integrity systems that identify suspect billing patterns, contract-analytics tools that scan terms for regulatory risk, and NLP-based review tools that analyze emails, policies, and other documentation for warning signs. Organizations may use platforms such as AuditBoard or Hyperproof for continuous control monitoring, while healthcare payers increasingly rely on AI-enabled claims-integrity and fraud, waste, and abuse detection platforms to surface improper billing before or after payment.

Used well, these tools can help compliance teams prioritize risk, reduce manual review burdens, and improve the consistency of internal oversight. Machine learning can identify anomalies across large datasets, natural language processing can assist in reviewing internal documentation and communications, and predictive analytics can help direct attention to issues that warrant further investigation. At the same time, AI should support—not replace—sound compliance judgment, escalation procedures, and human review.

How AI Can Increase Enforcement Risk

AI does not only benefit companies; it also gives enforcement agencies more efficient ways to identify and investigate potential False Claims Act violations. Automated data analysis can help uncover patterns associated with false claims, kickbacks, inaccurate certifications, or other misrepresentations, allowing investigators to focus resources more quickly and strategically. AI may also streamline document review and evidence organization, which can shorten investigative timelines and increase pressure on organizations that lack strong compliance controls, documentation, and remediation processes.

Why False Claims Act Enforcement Continues to Expand

Organizations should expect continued investment in False Claims Act enforcement because both enforcement agencies and oversight bodies continue to emphasize its economic value. In fiscal year 2025, the Department of Justice announced more than $6.8 billion in False Claims Act settlements and judgments, the highest annual total on record, with more than $85 billion recovered since 1986.

More broadly, the federal Inspector General community has reported that its monetary accomplishments represented approximately $18 for every $1 invested in fiscal year 2024, and other government and non-government sources have described similarly strong returns in healthcare fraud and oversight work. Together, those figures help explain why healthcare, government contracting, cybersecurity, and other federally funded activities remain under close scrutiny, and why organizations should treat compliance investments as a core risk-management function rather than a back-office exercise.

Key Considerations When Using AI in Compliance

AI can be a valuable compliance tool, but it also raises practical legal and operational issues. Before relying on AI in sensitive compliance functions, organizations should focus on the basics below.
- Data quality and reliability of the inputs used by the tool
- Privacy and confidentiality risks when sensitive data is processed
- Documentation showing how outputs are reviewed and used
- Validation and testing to confirm the tool performs as intended
- Oversight, escalation, and human review for high-risk decisions
Key Takeaways
- AI can strengthen compliance monitoring and help surface problems earlier.
- The same technology can also make government investigations more efficient.
- Organizations should pair AI tools with clear documentation, oversight, and human judgment.
As AI becomes more embedded in compliance and enforcement, organizations should assume that both internal monitoring expectations and external investigative capabilities will continue to increase. The practical question is no longer whether AI will affect False Claims Act risk, but whether an organization is using the technology carefully enough—and documenting its compliance efforts clearly enough—to reduce exposure when issues arise.
This entry was posted in Artificial Intelligence, Compliance Programs, Fraud and Abuse, Health Law Practice, Medical Practices, OFfice of Inspector General, Physician Compensation Issues. Bookmark the permalink.
Using Artificial Intelligence to Detect Potential Health Care Fraud

Posted on October 30, 2025 2:32 am by admin
How AI Can Mitigate or Create Fraud and Abuse Risks in the Healthcare Industry

The age of Artificial Intelligence is clearly upon us. Unless you are living in a cave it would be impossible not to understand that it will have an enormous impact on nearly every aspect of society, including the healthcare sector. It will have major economic and societal impacts. Some will be for the better and perhaps some “not so much.”

Artificial Intelligence is in use by the federal and state governments to detect patterns that may indicate potential fraud and abuse in the healthcare system. Health care providers are rushing to implement Artificial Intelligence as part of their operations and as part of their proactive corporate compliance program. Use of AI to detect fraud as part of a compliance program has become standard of care, particularly for larger organizations. Failure to use these tools to detect billing anomalies and other potential fraud and abuse could be used to impute knowledge of wrongdoing and trigger Federal False Claims Act liability.

What Is Artificial Intelligence (AI)?

Artificial Intelligence (AI), as defined in Executive Order 13960 and Section 238(g) of the National Defense Authorization Act (NDAA) of 2019, refers to artificial systems capable of performing tasks across diverse and unpredictable environments with limited human intervention, or systems that improve their performance by learning from new data and experiences. These systems may be implemented through software, hardware, or hybrid forms, and are developed to address challenges requiring capabilities such as human-like perception, cognition, planning, learning, communication, or physical action.

AI solutions are engineered to model or replicate human cognitive functions through architectures like neural networks and other advanced computational methods. Machine learning is a central technique that enables AI systems to approximate sophisticated cognitive processes. Additionally, the field encompasses systems designed for rational behavior, including intelligent agents and autonomous robots, which achieve specific objectives via perception, reasoning, planning, learning, communication, decision-making, and operational actions.

The concept of AI is frequently characterized as the emulation of human intelligence, encompassing faculties such as learning, complex problem-solving, rational behavior, autonomous execution, adaptability, and imitation of human activities. AI includes a broad range of sub-disciplines, each dedicated to replicating particular human abilities: natural language processing empowers systems to interpret and generate human languages; computer vision equips machines to analyze visual inputs; robotics integrates perception, analytical reasoning, and actuation; and reinforcement learning enables systems to enhance their behaviors based on environmental feedback.

AI systems are generally classified as either narrow—designed for specific, well-defined applications—or general, aimed at achieving flexible and adaptive performance comparable to human intelligence. At present, most leading AI technologies remain specialized; however, ongoing research is increasingly directed at developing broader, more contextually intelligent systems. As the field advances, ethical considerations, explainability, and transparency have become central concerns, with stakeholders demanding deeper understanding of system decision-making processes and operations.

In summary, artificial intelligence constitutes a dynamic and multidisciplinary field, drawing on knowledge from computer science, cognitive psychology, mathematics, engineering, and philosophy. Continued progress in AI consistently redefines the boundaries of machine capability, creating substantial opportunities while introducing new complexities across affected industries.

AI’s Potential to Transform Healthcare

Artificial intelligence (AI) has significant potential to transform various aspects of healthcare delivery. Its influence extends across administrative workflows, insurance verification, clinical decision support, reimbursable services, patient engagement, data analysis, revenue cycle management, billing, coding, compliance, care access, and scheduling. AI also contributes to reducing administrative burdens and after-hours documentation for physicians, which may help mitigate professional burnout and potentially enhance lifestyle.

As AI is increasingly integrated into healthcare systems, its impact is expected to be substantial. AI-driven solutions are already enhancing clinical workflows by increasing efficiency and facilitating the interpretation of large-scale patient data. Looking ahead, AI is poised to further advance healthcare through several key domains:
- Diagnostic Accuracy: Machine learning algorithms can rapidly and accurately analyze medical images, laboratory results, and detailed patient histories, supporting clinicians in earlier and more precise diagnosis. Decision support systems powered by AI synthesize evidence-based recommendations from research and patient data to inform personalized treatment strategies.
- Predictive Analytics: AI technologies can anticipate health events—such as hospital readmissions, adverse drug reactions, and disease outbreaks—by detecting patterns that might elude human analysis. This predictive capability enables proactive interventions and more effective resource allocation.
- Administrative Efficiency: AI streamlines essential processes including scheduling, coding, billing, and compliance review, thereby decreasing clerical workloads. Automated virtual assistants can manage appointments, address patient inquiries, and facilitate follow-up care, resulting in improved provider productivity and enhanced patient engagement.
- Expanding Access to Care: Telemedicine platforms powered by AI can triage patient symptoms, guide self-care practices, and connect individuals with specialists regardless of geographic limitations. Furthermore, natural language processing tools can translate medical information and simplify terminology to improve communication and comprehension for patients.
The integration of AI within healthcare is deepening, driving efficiency and accuracy while fostering a shift toward personalized, preventive, and accessible medicine. As these technologies continue to evolve, their capacity to learn from diverse datasets, adapt to new developments, and deliver real-time insights will empower clinicians to address emerging health challenges and deliver higher-quality care.

Despite its transformative promise, the adoption of AI in healthcare also raises important challenges. Issues related to data privacy, algorithmic bias, and the need for rigorous validation of AI tools must be addressed to ensure patient safety and equitable care. Additionally, integrating AI into clinical practice requires ongoing training for healthcare professionals and robust regulatory frameworks to oversee the deployment and monitoring of AI-driven solutions. Balancing innovation with ethical responsibility will be essential as AI continues to shape the future of healthcare delivery.

Furthermore, AI-enabled remote monitoring tools and wearable devices are increasingly being used to track patient health metrics in real time, allowing for early detection of complications and more responsive care. These advancements not only support continuous patient monitoring outside traditional clinical settings but also enable healthcare providers to deliver more timely and tailored interventions. As AI-driven innovations proliferate, collaborative efforts between technologists, clinicians, and policymakers will be critical to maximize benefits while addressing emerging ethical and operational concerns.

Summary

Artificial intelligence is revolutionizing healthcare by streamlining administrative tasks, enhancing diagnostic accuracy, enabling predictive analytics, and expanding access to care through telemedicine and remote monitoring. While AI promises improved efficiency, personalized treatment, and proactive interventions, its adoption presents challenges such as data privacy, algorithmic bias, and the need for strong regulatory oversight. Ongoing collaboration and ethical considerations are essential to harness AI’s full potential in delivering high-quality, equitable healthcare.

For more information, contact your PhysiciansHealthLawyers.com healthcare attorney.
This entry was posted in AntiKickback Statute and Regulations, Artificial Intelligence, Billing and Reimbursement, Compliance Programs, Fraud and Abuse, Health Law Practice, Medical Practices and tagged AI Fraud Preventions, AI in Compliance, Artificial Intelligence, fraud and abuse, Fraud Detections. Bookmark the permalink.
Senate Subcommittee (November 2023): Policy Considerations for AI in Health Care

Posted on December 9, 2024 12:03 pm by admin
In November 2023, the Subcommittee on Primary Health and Retirement Security under the Senate Committee on Health, Education, Labor and Pensions held a hearing to examine the implications of artificial intelligence (AI) in health care. The hearing brought together lawmakers, technology experts, health care professionals, ethicists, and patient advocates to evaluate both the opportunities and challenges associated with AI’s integration into health care delivery.

Key Findings
- Potential for Enhanced Care: AI tools demonstrate significant promise in improving clinical decision-making, streamlining administrative functions, and increasing access to quality care, particularly for underserved populations.
- Risks of Inaccuracy and Bias: There are concerns regarding AI’s potential to perpetuate or worsen existing biases in health data, possibly resulting in inaccurate diagnoses or unequal care for marginalized groups.
- Transparency and Explainability: The need for transparent and explainable AI models was emphasized to ensure clinicians and patients can understand the rationale behind AI-driven decisions.
- Data Privacy and Security: Witnesses highlighted the critical importance of safeguarding sensitive patient data, stressing the necessity for strong protections and compliance with privacy regulations.
- Regulatory Oversight: The Subcommittee discussed the need for regulatory frameworks that evolve with technological innovation while still promoting beneficial advancements.
- Workforce Impact: Testimony addressed how AI could affect the health care workforce, underlining the importance of ongoing training and adaptation for clinicians.
- Patient Involvement: Including patient perspectives in the design, deployment, and oversight of AI systems was recognized as essential for building trust and ensuring effectiveness.
Recommendations
- Develop and implement rigorous standards for AI transparency, accuracy, and fairness in health care applications.
- Increase federal investments in research to address data bias, model validation, and the safety of AI-enabled clinical tools.
- Establish clear guidelines for the ethical use of patient data, ensuring robust privacy protections and informed consent.
- Promote multidisciplinary collaboration among technologists, clinicians, ethicists, and patient representatives in AI development and deployment.
- Encourage ongoing education and training programs for health care professionals to keep pace with AI’s evolving role in practice.
- Strengthen oversight mechanisms to monitor AI systems’ real-world performance and impact, including pathways for reporting and addressing adverse outcomes.
Conclusion

The Subcommittee concluded that AI holds transformative potential for health care, but realizing these benefits requires thoughtful policy design, vigilant oversight, and unwavering commitment to equity, transparency, and patient safety. Legislative strategies will continue to be developed to foster innovation while prioritizing the interests of patients and providers.

AI Use and Associated Concerns
- AI tools can record and summarize doctor-patient conversations, with physicians editing AI-generated summaries, allowing the AI to learn from these edits.
- Concerns include the necessity of physician oversight, potential errors in coverage decisions, and the challenge of understanding how AI produces its outputs.
This entry was posted in AntiKickback Statute and Regulations, Artificial Intelligence, Fraud and Abuse, Health Law Practice and tagged AI Fraud Detection, ai healthcare, AI in Compliance Programs, Artificial Intelligence. Bookmark the permalink.
Compliance Officer Authority and Resource Allocation

Posted on July 24, 2024 7:19 am by admin
The Department of Justice (DOJ) uses resource allocation as a key measure when evaluating the effectiveness of compliance programs. Allocating sufficient resources to the compliance function is foundational to any systematic compliance initiative and remains central as regulatory expectations evolve. The DOJ assesses resource allocation alongside compliance officer autonomy, highlighting the strong connection between these two factors in achieving effective compliance oversight.

Compliance Officer Authority and Autonomy: Cornerstones of Effectiveness

For a compliance program to function effectively, the compliance officer must have both the authority and autonomy necessary to carry out oversight and enforcement duties. Insufficient funding represents a structural weakness that can undermine the credibility and operation of the program. Many organizations reinforce compliance officer autonomy by providing employment protections or financial safeguards in cases of compliance-related terminations or resignations. This autonomy allows compliance officers to address issues throughout the organization without fear of retaliation or loss of resources.

Best practices have long recommended that compliance officers hold senior management positions and report directly to the board of directors. This reporting structure ensures the independence needed to address compliance issues at every organizational level and is increasingly viewed as a hallmark of program effectiveness.

The Interrelationship Between Resource Allocation and Compliance Officer Autonomy

Resource allocation and compliance officer authority are deeply linked. Dedicated funding is necessary to maintain compliance independence; if compliance officers rely on other departments for resources, their ability to operate impartially can be compromised. To ensure true independence, organizations should allocate a segregated budget for compliance activities, allowing the compliance officer to justify expenses directly to the board of directors, rather than seeking supplemental funds from unrelated departments.

DOJ Guidelines: Emphasis on Autonomy and Resource Allocation

DOJ guidelines underscore the importance of compliance officer autonomy and adequate resource allocation. Prosecutors are directed to assess whether compliance personnel:
- Hold appropriate seniority within the organization
- Have sufficient staff and resources for thorough auditing, documentation, and analysis
- Maintain independence from management, such as having direct access to the board or audit committee
Challenges in Compliance Budgeting

Budgeting for compliance is often complex, as these costs do not directly generate new business initiatives and compliance is frequently viewed as a cost center. This makes it difficult for executives to justify compliance expenditures, especially when compared to investments in program expansion or operational improvements. The value of a robust compliance budget often becomes clear only after major incidents, highlighting the need for proactive resource allocation.

Determining Adequate Compliance Resources

The appropriate budget for compliance depends on the organization’s size, structure, and risk profile. There is no universal standard for sufficient funding. The DOJ notes that larger organizations typically require more resources, while smaller entities may operate effectively with fewer formal processes and assets. Industry surveys provide benchmarks but may omit certain costs, such as incident investigations or legal counsel. Ultimately, organizations must use sound judgment to ensure all essential elements—appointing a compliance officer, establishing core processes, identifying risks, and implementing mitigation strategies—are adequately supported, regardless of size.

Scalability Considerations

Organizations, particularly those of mid-size, should be cautious about relying solely on scalability when determining compliance budgets. Failing to address critical risk areas can leave businesses exposed to regulatory scrutiny or whistleblower actions. It is advisable to proactively identify and mitigate risks, regardless of the organization’s size or perceived risk level.

Elements of an Effective Compliance Program

A successful compliance program assesses risk profiles, prioritizes audits and remediation, and works continuously to minimize organizational risks. Smaller entities may require proportionally fewer resources but must still address key risk areas thoroughly.

Segregation of Compliance Budget and Officer Access

The compliance budget should be distinct and not sourced from multiple departments. Direct access to allocated funds allows compliance officers to act independently and responsibly within set budgetary limits, free from undue restrictions on legitimate expenditures. Budgeting should align with the compliance work plan and reflect the organization’s stage of compliance development. Organizations new to compliance may need additional support to address emerging issues and build robust procedures.

Supporting Board Oversight with Expert Resources

A well-structured compliance budget should ensure the board of directors has access to specialized expertise in relevant regulatory areas. Prosecutors will review whether companies have invested in qualified personnel and consultative support tailored to industry-specific risks. For instance, healthcare organizations should prioritize legal professionals with experience in health law to support both compliance operations and board decision-making. Organizations facing budget constraints may consider non-specialized counsel, but this could compromise compliance oversight and increase regulatory risk for the board.

Key Questions for Prosecutors Assessing Compliance Budgeting and Autonomy

The DOJ provides guidance for prosecutors to evaluate whether compliance offices are adequately funded and sufficiently autonomous. Key questions include:
- Structure: Where is the compliance function located within the company? To whom does it report? Is it led by a designated chief compliance officer, and does this individual hold other roles? Are compliance personnel solely dedicated to compliance or do they have additional responsibilities? What is the rationale for the chosen structure?
- Seniority and Stature: How does the compliance function’s status compare to other strategic units in terms of rank, compensation, resources, and influence? What is the turnover among compliance staff? How is compliance integrated into strategic and operational decisions? How does the company respond to compliance concerns? Have transactions been modified as a result of compliance interventions?
- Experience and Qualifications: Do compliance staff have appropriate qualifications and experience? How have these attributes evolved? How is performance evaluated and by whom?
- Funding and Resources: Is staffing sufficient for necessary compliance activities? Has the company provided adequate funding? If requests were denied, what was the rationale?
- Autonomy: Do compliance and control functions report directly to the board or audit committee? How frequently are meetings held, and is senior management present? What measures support the independence of compliance personnel?
Conclusion

Organizations should design and manage compliance programs with the expectation that they may need to demonstrate program effectiveness in regulatory proceedings, such as False Claims Act or Fraud and Abuse cases. High-stakes situations require clear evidence of robust compliance. Programs lacking segregated budgets and independent authority face significant challenges in proving effectiveness before regulators. Proactive, properly resourced compliance programs are essential for mitigating risk and protecting organizational integrity.

For more information, contact your PhysiciansHealthLawyers.com healthcare attorney.
This entry was posted in Billing and Reimbursement, Compliance Programs, Fraud and Abuse, HIPAA Issues, OFfice of Inspector General, Safe Harbor Regulations, Stark Law, Uncategorized and tagged Compliance Budget, Compliance Officer Authority, compliance programs, Corporate Compliance Officer. Bookmark the permalink.
Apply the 60-Day Repayment Rule to Medicaid Overpayments

Posted on May 30, 2019 8:13 am by admin

Overview of Overpayment Reporting and Repayment

The Affordable Care Act (ACA) imposes specific requirements on individuals and entities that receive overpayments from designated government health programs. Under the ACA, any person who has received an overpayment from programs such as Medicare Part A, Medicare Part B, Medicare Advantage, Medicaid Fee-for-Service, and Medicaid Managed Care is required to report and return the overpayment within 60 days after the overpayment is identified. Failure to repay or self-disclose the overpayment within this 60-day window results in the amount becoming subject to penalties under the federal False Claims Act (FCA).

False Claims Act Penalties

The FCA is a federal law that enforces strict penalties for non-compliance with overpayment repayment obligations. Specifically, the FCA imposes damages amounting to three times the actual overpayment, in addition to a per-claim penalty that ranges from approximately $11,000 to $22,000. These substantial penalties serve as a strong incentive for providers to promptly self-disclose and repay any identified overpayments.

Importance of Effective Compliance Programs

Given the severity of FCA penalties, providers are strongly incentivized to operate effective compliance programs. The FCA applies a “should know” standard, which means that providers are expected to have systems in place to proactively identify and audit potential risk areas. An effective compliance program demonstrates that a provider is making reasonable efforts to detect and address overpayments before they become a liability.

Clarification of the 60-Day Repayment Rule

To avoid FCA penalties, repayment must be made within 60 days after the overpayment is identified or when a corresponding cost report is due. Recent regulations have provided some assistance in defining when a provider is considered to have “identified” an overpayment and when the 60-day period officially begins. However, these clarifications primarily apply to Medicare program overpayments, while regulations specific to Medicaid remain absent.

Scope and Application of Repayment Obligations

The statute’s repayment obligation is broadly applicable and extends clearly to the Medicaid program. Despite this, clarifying regulations have only been adopted for Medicare, leaving providers without guidance on compliance details for Medicaid overpayments. The statutory requirement for Medicaid mandates repayment within 60 days of discovery, but there is no regulatory detail explaining how to fulfill this obligation.

Medicare Parts A and B Final Rule

On February 12, 2016, the Centers for Medicare & Medicaid Services published the Medicare Parts A and B Final Rule. These rules provided important clarifications, such as defining when a provider is deemed to have discovered an overpayment and establishing the length of the “look-back” period. The look-back period determines how far back providers must go to identify overpayments once they suspect an infraction has occurred. While early Medicare regulations set a 10-year look-back, the 2016 rules reduced this to six years for Medicare overpayments. Notably, these regulations explicitly state that they do not apply to Medicaid overpayments, leaving the look-back period for Medicaid undefined.

Unresolved Issues for Medicaid Overpayments

Several critical areas of ambiguity persist regarding Medicaid overpayments. Key among these are the determination of the look-back period and the point at which an overpayment is deemed “identified.” While providers cannot ignore potential overpayments once a problem is identified, there is no guidance on whether the six-year Medicare look-back period, the earlier 10-year period, or another timeframe should apply to Medicaid. Likewise, it remains unclear whether providers can rely on the regulatory interpretations for the start of the 60-day clock for Medicaid overpayments.

Current Practices and Uncertainty

In practice, overpayments are often identified when a specific employee, department, or service area systematically makes a mistake in billing or documentation, and these errors typically span across both Medicare and Medicaid. As it stands, there is regulatory clarification for handling Medicare overpayments, but no similar guidance for Medicaid, resulting in uncertainty for providers.

Potential Approaches for Providers

Providers facing both Medicare and Medicaid overpayments are left to determine how best to fulfill their statutory obligations. Questions remain as to whether they should follow Medicare rules for Medicaid overpayments or await further regulatory guidance. The absence of Medicaid-specific regulations means providers must navigate this uncertainty, knowing that following Medicare regulations may not be fully appropriate or sufficient, and that future test cases could clarify these obligations.

Conclusion

Until Medicaid regulations are released, providers must contend with ongoing uncertainty regarding how to handle Medicaid overpayments. The ACA’s requirements are clear in their broad application, but the lack of regulatory detail for Medicaid repayments means providers must exercise caution and remain vigilant in their compliance efforts.

This entry was posted in AntiKickback Statute and Regulations, Billing and Reimbursement, Fraud and Abuse, OFfice of Inspector General, Safe Harbor Regulations, Stark Law, Uncategorized and tagged 60 Day Rule, 60-Day Repayment, False Claims Act, fraud and abuse, Identifying overpayments, Overpayments. Bookmark the permalink.
The Incentive to Self Disclose False Claims Act Overpayments

Posted on May 28, 2019 11:22 am by admin

Proactive Compliance and Regulatory Oversight

The Department of Justice (DOJ), in collaboration with other regulatory agencies, places a strong emphasis on the proactive monitoring of compliance by businesses. Recognizing that governmental resources alone are insufficient to uncover every instance of fraud and abuse, the DOJ expects entities to take an active role in adhering to relevant regulations. This proactive stance requires organizations to consistently monitor their operations and promptly address any compliance concerns that arise.

Updated DOJ Guidelines on Cooperation in FCA Matters

Recently, the DOJ released updated guidelines specifically addressing cooperation in False Claims Act (FCA) matters. These guidelines highlight the critical importance of proactive compliance, voluntary self-disclosure, and active cooperation in civil FCA investigations. This message is especially relevant for health care providers who routinely submit claims, underscoring the need for vigilance and transparency in their compliance efforts.

Establishing Comprehensive Compliance Programs

Reflecting these expectations, organizations are now required to implement comprehensive compliance programs. Such programs should encompass regular training for staff, thorough internal audits, and robust reporting mechanisms. By integrating these elements, businesses are better positioned to detect and address potential violations early, thereby preventing minor issues from escalating into significant legal or regulatory problems.

Value of Cooperation and Self-Disclosure

According to the updated guidelines, the DOJ places a high value on organizational cooperation and voluntary self-disclosure throughout its investigative processes. Organizations are therefore advised to incorporate these principles into their compliance programs, fostering a culture of transparency and cooperative engagement with government authorities.

Benefits of Timely and Meaningful Cooperation

Entities that demonstrate timely and meaningful cooperation with the DOJ may be eligible for reduced penalties or more favorable outcomes in enforcement actions. This approach not only helps mitigate potential risks but also reinforces a culture of integrity and ethical conduct throughout the organization.

Emphasis on Individual Accountability and Rigorous Compliance

Building upon earlier policy statements encouraging voluntary disclosure, the DOJ’s recent updates further stress the need for rigorous internal compliance measures. There is now a heightened focus on individual accountability within organizations, reflecting the government’s commitment to fostering responsible corporate behavior and proactive management of compliance obligations.

Fostering a Culture of Accountability and Integrity

In response to these developments, organizations are encouraged to bolster their compliance infrastructures and create an environment where accountability is embedded at every level. This involves empowering employees to identify and report concerns, ensuring that leadership consistently models ethical behavior, and integrating strong oversight into daily operations. Such a comprehensive approach enables organizations to identify and correct issues swiftly, demonstrating a genuine commitment to compliance and reinforcing public trust.

Summary

In conclusion, federal authorities strongly advocate for organizations to manage compliance proactively, promptly self-report potential violations, and maintain active collaboration with enforcement efforts. Adhering to these principles not only helps organizations meet regulatory expectations but also cultivates a culture of transparency, ethical conduct, and trust.

This entry was posted in AntiKickback Statute and Regulations, Compliance Programs, Fraud and Abuse, Uncategorized and tagged DOJ Dislcosure, False Claims Act, fraud and abuse, Protocol for Self Disclosure, Repayment of Overpayments, self disclosure, Self Reporting. Bookmark the permalink.
Billing Fraud Claims By Employees – What Not To Do

Posted on May 22, 2019 8:39 am by admin

What Not To Do If An Employee Alleges Fraud

In the course of some reading on anesthesia billing issues, I came across a case from 2002 that clearly describes how not to handle an employee who alleges that your practice may have a billing problem.

Brandon v. Anesthesia & Pain Management Associates, Ltd., 277 F.3d 936 (2002) involved a physician who became suspicious that other members of his anesthesia group may have been pumping up the billings a bit. Specifically, the physician felt that other members of his group may have been falsifying the number of operations that they were supervising in order to qualify for “medically directed” reimbursement rates. He also alleged that members of the group may have altered billing sheets to indicate that they had performed work, even though they had left the hospital for the day.

It is not clear from the case whether the physician’s allegations were true or proved. However, the reaction of the anesthesia group where the physician raised these issues was far short of ideal from a legal standpoint.

The allegations were raised by the physician during a board meeting. A few weeks after the disclosure, the physician was told that he should start looking for other work. The physician asked for more information on his shortcomings and was not provided with any details. At that point, he began keeping a journal of suspected billing problems. A few months later, the physician was notified that he would be required to leave his job by the end of the year. The physician reiterated his complaints at that point. The complaints were met with strong, vulgar language (which you can read in the case). He was told that he did not have a contract and that the group would make life difficult for him if he did not resign.

The group was found to have violated Illinois’ retaliatory discharge laws for taking action against the physician who had alleged billing fraud. The court upheld the state law claim even though the Federal False Claims Act provided a civil remedy for the physician.

It should be pointed out that the physician had a possible claim as a “qui tam” litigant under the False Claim Act, assuming the facts described in the complaint were true.

This case provides a textbook example of how “not to” address employee allegations of billing deficiencies. All such allegations should be taken seriously and investigated. Your practice should adopt compliance policies to provide procedures to follow when employees or others make complaints. Handling complaints in the manner of the group in this case, exposes the group to a great deal of unnecessary risk. Once a complaint is made, make sure is it investigated. If there is a problem, take appropriate steps to remedy the situation. In some cases, this may require self-disclosure and repayment. When in doubt about what to do, consult your health care compliance attorney.

This entry was posted in Billing and Reimbursement, Fraud and Abuse, Health Law Practice, Medical Practices, OFfice of Inspector General, Radiology Issues. Bookmark the permalink.
DOJs New Evaluation of Corporate Compliance Programs – The Essence of Compliance

Posted on May 20, 2019 1:44 pm by admin

The Criminal Division of the United States Department of Justice (DOJ) revised its Evaluation of Corporate Compliance Programs in April 2019. Initially introduced in 2017, this document provides prosecutors with structured guidance for investigations, charging decisions, and plea negotiations. The Evaluation serves as a practical tool for gauging the effectiveness of corporate compliance programs, and is frequently referenced by organizations when developing or revising their own compliance frameworks.

As organizations navigate an increasingly complex regulatory landscape, understanding the Department of Justice’s evolving expectations is critical for building a compliance program that withstands scrutiny. By proactively addressing guidance updates, companies can better anticipate enforcement trends and mitigate potential liabilities.

The recent updates are intended to align the Evaluation more closely with other compliance-related resources and the legal principles that inform compliance obligations. Notably, the DOJ has increased its focus on the actual effectiveness of corporate compliance programs and the accountability of individuals involved in violations—a priority underscored by the “Yates Memorandum,” which emphasizes personal responsibility in cases of corporate misconduct.

These changes underscore the DOJ’s expectation that organizations not only develop robust compliance policies on paper but also implement them effectively in practice, ensuring that compliance functions are integrated into everyday business operations. By focusing on tangible outcomes—such as timely detection and remediation of misconduct, clear disciplinary procedures, and demonstrable leadership commitment—the Evaluation encourages companies to move beyond formalistic approaches and build a culture of ethical conduct. Instead of merely summarizing the Evaluation, this analysis will utilize its principal topics as an organizational framework to examine best practices in effective compliance program implementation. This methodology facilitates a comprehensive discussion of the essential steps required to establish robust, adaptable compliance systems that address emerging risks promptly.

Rather than providing a simple summary of the Evaluation, this analysis will employ its key topics as an organizational structure to assess best practices in the implementation of effective compliance programs. This approach enables a thorough discussion of the critical steps necessary to develop resilient and flexible compliance systems capable of responding swiftly to emerging risks.

By structuring our analysis in this manner, we can offer actionable recommendations tailored to each dimension of the DOJ’s framework, helping organizations not only interpret regulatory expectations but also translate them into concrete operational practices. This will allow readers to gain a nuanced understanding of how effective compliance programs are designed, implemented, and sustained within dynamic business environments, setting the stage for subsequent blog posts that will delve into each core area identified in the Evaluation, drawing on DOJ guidance to offer detailed insights into how the various components of compliance collectively contribute to a comprehensive risk management framework.

Subsequent blog posts will address each core area identified in the Evaluation, drawing on DOJ guidance to offer detailed insights into how the various components of compliance collectively contribute to a comprehensive risk management framework.

We invite you to subscribe to our RSS feed and follow our series as we examine the foundations of effective corporate compliance.

This entry was posted in Compliance Programs, Fraud and Abuse, HIPAA Issues, Uncategorized and tagged 2016 Work Plan, Corporate Compliance Programs, fraud and abuse, Healthcare Compliance. Bookmark the permalink.
IT Donation to Facilitate Telemedicine Consultations – Low Risk of Fraud says OIG

Posted on June 17, 2018 9:39 am by admin

The Office of Inspector General (“OIG”) of the U.S. Department of Health and Human Services issued Advisory Opinion No. 18-03 in support of an arrangement where a federally qualified health center look-alike (the “Provider”) would donate free information technology-related equipment and services to a county health clinic (the “County Clinic”) to facilitate telemedicine encounters with the County Clinic’s patients (the “Proposed Arrangement”). The OIG concluded that although the Proposed Arrangement could potentially generate prohibited remuneration under the federal Anti-Kickback Statute (“AKS”) and Civil Monetary Penalties Law (“CMPL”) with the requisite intent to induce or reward referrals of federal health care programs, the OIG would exercise its discretion and not sanction the Provider or the County Clinic (collectively the “Requestors”).

The OIG’s analysis and conclusion of the Proposed Arrangement provides new insight into the government’s position on these type of donations that facilitate telemedicine encounters. Specifically, how the government views these type of donations with the continued expansion of coverage and reimbursement of telemedicine services under federal health care programs. The Advisory Opinion indicates support for the development of collaborative telemedicine affiliations and that the potential remuneration from the future referrals can be outweighed by the access to health care services and benefits actually received by rural or remote communities.

The County Clinic is a division of the County Department of Health that furnishes certain confidential sexually transmitted infection testing, treatment and counseling. The Provider has an existing referral relationship with the County Clinic but the facilities are separated by about 80 miles making it difficult for patients to access the Provider. Under the Proposed Arrangement, the Provider would donate information technology-related equipment and services to the County Clinic to facilitate telemedicine encounters between the Provider and the County Clinic’s patients for certain HIV prevention and treatment services. The Provider would cover the costs of the equipment, its set up, and maintenance through grant-funding from the State Department of Health. The Provider would bill the Medicare program for the professional services delivered in the telemedicine encounters. The County Clinic would house the equipment and bill the state Medicaid program an originating site fee related to the telemedicine encounters. The originating site is not required to provide any personnel or equipment in order to bill for the facility fee (Q3014) (which is only a coverage requirement to provide the telehealth consult).

This entry was posted in AntiKickback Statute and Regulations, Fraud and Abuse, Health Law Practice, Medicare, OFfice of Inspector General, OIG Advisory Opinions. Bookmark the permalink.
Federal Developments May Ease Certain Health Care Compliance Burdens

Posted on March 16, 2018 11:09 am by admin
DOJ Limits Use of Agency Guidance in Civil Enforcement

Key Takeaway: Recent federal developments may provide health care providers with additional flexibility in meeting certain regulatory requirements. Most notably, the U.S. Department of Justice (DOJ) has limited how its attorneys may rely on agency guidance in civil enforcement actions, while the Bipartisan Budget Act of 2018 codifies flexibility for several technical Stark Law requirements.

Health care providers have long faced compliance risk where federal agencies issued guidance documents that were later used in enforcement matters as evidence of legal obligations. That approach is changing. In November 2017, U.S. Attorney General Jeff Sessions issued a memorandum stating that DOJ guidance documents may not create binding rights or obligations for parties outside the Executive Branch.

In January, Associate Attorney General Rachel Brand reinforced that position in what is now commonly referred to as the “Brand Memo.” The memo directs DOJ litigators not to use agency guidance documents to create “de facto regulations” and not to prove a violation of law based solely on a party’s failure to comply with guidance.

Why this matters: The change may reduce enforcement risk tied to informal agency interpretations that have not gone through formal rulemaking. DOJ attorneys may still rely on statutes, regulations, and other binding legal authorities, but agency guidance alone should no longer serve as the basis for proving noncompliance.

Stark Law Changes Provide Technical Compliance Flexibility

The Bipartisan Budget Act of 2018 also provides relief for certain technical requirements under the Stark Law. The changes largely codify prior Centers for Medicare & Medicaid Services (CMS) guidance and regulations addressing written agreements, signatures, and holdover arrangements.

The Stark Law generally requires certain physician compensation arrangements to satisfy an applicable exception, many of which include strict writing and signature requirements. Historically, otherwise compliant arrangements could create risk if documentation was incomplete, unsigned, or not contained in a single agreement.

Under the Budget Act, the writing requirement may be satisfied through a “collection of documents,” including contemporaneous records showing the parties’ course of conduct. The Act also allows required signatures to be obtained within 90 days after the arrangement should have been signed, provided the arrangement otherwise satisfies the applicable Stark Law exception.

The Budget Act further allows certain expired office space leases, equipment leases, and personal services arrangements to remain protected during a holdover period, so long as the arrangement continues on the same terms and conditions.

Practical impact: These revisions may help providers avoid disproportionate consequences for technical documentation defects, particularly where the underlying arrangement otherwise complies with Stark Law requirements. Providers should not treat the changes as eliminating documentation obligations, but they may offer useful flexibility when reviewing existing physician arrangements.

Recommended Next Steps for Providers
- Review current physician compensation arrangements, leases, and personal services agreements for documentation gaps.
- Confirm that any reliance on agency guidance is distinguished from binding statutory or regulatory requirements.
- Update compliance policies and training materials to reflect the DOJ’s revised approach to guidance documents.
- Consider whether any unsigned or expired arrangements may be addressed under the new Stark Law flexibility.
This entry was posted in AntiKickback Statute and Regulations, Billing and Reimbursement, Fraud and Abuse, Safe Harbor Regulations, Stark Law, Uncategorized and tagged 2016 Work Plan. Bookmark the permalink.
CMS Stark Law Self Disclosure – New Form and Process for Self Disclosing Stark Law Violations

Posted on April 13, 2017 10:06 am by admin

The Centers for Medicare and Medicaid Services (CMS) has issued new forms and procedures for provider self-disclosure of Stark Law violations. The new material is intended to streamline the process that permits providers to self-disclose Stark Law violations. The process is applicable to violations that only implicate the Stark Law. The OIG maintained a different process that can be considered when there are potential civil monetary penalty violations. The new forms and process are mandatory beginning June 1, 2017 CMS encourages providers to begin using the new process immediately.

The new self disclosure procedures can be found through the CMS self referral disclosure page.

This entry was posted in Fraud and Abuse, Health Law Practice, Physician Compensation Issues, Stark Law and tagged CMS protocols, self disclosure, stark law disclosures. Bookmark the permalink.
Remuneration Under the Stark Law I Stark Regulations Definition

Posted on April 12, 2017 10:22 am by admin

Remuneration Defined Under the Stark Law Regulations

Remuneration means any payment or other benefit made directly or indirectly, overtly or covertly, in cash or in kind, except that the following are not considered remuneration for purposes of this section:

(1) The forgiveness of amounts owed for inaccurate tests or procedures, mistakenly performed tests or procedures, or the correction of minor billing errors.

(2) The furnishing of items, devices, or supplies (not including surgical items, devices, or supplies) that are used solely for one or more of the following purposes:

(i) Collecting specimens for the entity furnishing the items, devices or supplies;

(ii) Transporting specimens for the entity furnishing the items, devices or supplies;

(iii) Processing specimens for the entity furnishing the items, devices or supplies;

(iv) Storing specimens for the entity furnishing the items, devices or supplies;

(v) Ordering tests or procedures for the entity furnishing the items, devices or supplies; or

(vi) Communicating the results of tests or procedures for the entity furnishing the items, devices or supplies.

(3) A payment made by an insurer or a self-insured plan (or a subcontractor of the insurer or self-insured plan) to a physician to satisfy a claim, submitted on a fee-for-service basis, for the furnishing of health services by that physician to an individual who is covered by a policy with the insurer or by the self-insured plan, if—

(i) The health services are not furnished, and the payment is not made, under a contract or other arrangement between the insurer or the self-insured plan (or a subcontractor of the insurer or self-insured plan) and the physician;

(ii) The payment is made to the physician on behalf of the covered individual and would otherwise be made directly to the individual; and

(iii) The amount of the payment is set in advance, does not exceed fair market value, and is not determined in a manner that takes into account directly or indirectly the volume or value of any referrals.

This entry was posted in Fraud and Abuse, Medicare, Physician Compensation Issues, Stark Law and tagged Defined Terms, Financial Relationships, Remuneration, Stark Law, Stark Regulations. Bookmark the permalink.
Designated Health Services Definition I Stark Law DHS Defined

Posted on April 12, 2017 10:17 am by admin

Definition of Designated Health Services under the Stark Law Regulations

Designated health services (DHS) means any of the following services (other than those provided as emergency physician services furnished outside of the U.S.), as they are defined in this section:

(1)(i) Clinical laboratory services.

(ii) Physical therapy, occupational therapy, and outpatient speech-language pathology services.

(iii) Radiology and certain other imaging services.

(iv) Radiation therapy services and supplies.

(v) Durable medical equipment and supplies.

(vi) Parenteral and enteral nutrients, equipment, and supplies.

(vii) Prosthetics, orthotics, and prosthetic devices and supplies.

(viii) Home health services.

(ix) Outpatient prescription drugs.

(x) Inpatient and outpatient hospital services.

(2) Except as otherwise noted in this subpart, the term “designated health services” or DHS means only DHS payable, in whole or in part, by Medicare. DHS do not include services that are reimbursed by Medicare as part of a composite rate (for example, SNF Part A payments or ASC services identified at §416.164(a)), except to the extent that services listed in paragraphs (1)(i) through (1)(x) of this definition are themselves payable through a composite rate (for example, all services provided as home health services or inpatient and outpatient hospital services are DHS).

This entry was posted in Compliance Programs, Fraud and Abuse, Physician Compensation Issues, Stark Law and tagged Defined Terms, Designated Health Services, Stark Law, Stark Regulations. Bookmark the permalink.
← Older posts

Understanding FCA Risks and How Compliance Can Protect Your Practice

FCA Liability: What Triggers It?

Fictitious Damages Calculation: Systematic Billing Error Scenario

Astronomical Damages: Financial Risks and Impact

The Importance of Compliance Programs

Conclusion: Key Takeaways and Recommendations

Principal Issue of CPOM in Telehealth

Listen to our Legal Pulse Podcast on CPOM in Telehealth

Why CPOM in Telehealth Matters

What Is the Corporate Practice of Medicine in Telehealth?

How CPOM Affects Telehealth Business Models

Management Service Organization and CPOM in Telehealth

Document Flow of Funds to Mitigate CPOM in Telehealth

Common Red Flags in Telehealth CPOM Structures

CPOM in Telehealth Compliance Checklist

Frequently Asked Questions About CPOM in Telehealth

Does CPOM apply to telehealth companies?

Can an MSO manage a telehealth practice?

Why are percentage-based fees risky in telehealth?

What is the difference between CPOM and fee splitting?

When should a telehealth company review CPOM compliance?

Can one telehealth corporate practice of medicine structure work nationwide?

Address CPOM Issues in Telehealth

Conclusions About CPOM in Telehealth

Lessons from a Real-World Case Study in Ambulatory Surgery Center Ownership

A Cautionary Tale: The Silent Partner Physician

Segment 1 — The Setup

Segment 2 — The Pattern Emerges

Key Takeaways for ASC Owners and Administrators

Conclusion

Stark Law Period of Disallowance Guide for Healthcare Professionals

What is Stark Law Period of Disallowance

Legal Background on the What is Stark Law Period of Disallowance

Stark Law Period of Disallowance Calculation Methods

Implications for Healthcare Providers

Practical Examples Stark Law Period of Disallowance

Best Practices for Managing Disallowance Periods

Regulatory Developments Impacting Medical Practice Structures and Ancillary Services

1. Stark Law and Anti-Kickback Statute Updates

2. State-Level Scope of Practice Reforms

3. Telehealth Expansion and Reimbursement Policies

4. Corporate Practice of Medicine and Management Services Organizations

5. Ancillary Service Billing and Compliance

Conclusion

What AI Means for Compliance Programs

How AI Can Increase Enforcement Risk

Why False Claims Act Enforcement Continues to Expand

Key Considerations When Using AI in Compliance

Key Takeaways

How AI Can Mitigate or Create Fraud and Abuse Risks in the Healthcare Industry

What Is Artificial Intelligence (AI)?

AI’s Potential to Transform Healthcare

Summary

Key Findings

Recommendations

Conclusion

AI Use and Associated Concerns

Compliance Officer Authority and Autonomy: Cornerstones of Effectiveness

The Interrelationship Between Resource Allocation and Compliance Officer Autonomy

DOJ Guidelines: Emphasis on Autonomy and Resource Allocation

Challenges in Compliance Budgeting

Determining Adequate Compliance Resources

Scalability Considerations

Elements of an Effective Compliance Program

Segregation of Compliance Budget and Officer Access

Supporting Board Oversight with Expert Resources

Key Questions for Prosecutors Assessing Compliance Budgeting and Autonomy

Conclusion

Overview of Overpayment Reporting and Repayment

False Claims Act Penalties

Importance of Effective Compliance Programs

Clarification of the 60-Day Repayment Rule

Scope and Application of Repayment Obligations

Medicare Parts A and B Final Rule

Unresolved Issues for Medicaid Overpayments

Current Practices and Uncertainty

Potential Approaches for Providers

Conclusion

Proactive Compliance and Regulatory Oversight

Updated DOJ Guidelines on Cooperation in FCA Matters